Package 31722-315-90

{"route": ["ORAL"], "spl_id": "097eb368-0559-467f-8a1e-1082e82c15ed", "openfda": {"nui": ["N0000000151", "N0000175784", "N0000000160", "M0001335", "N0000175722"], "upc": ["0331722315906"], "unii": ["5QZO15J2Z8", "WK2XYI10QM"], "rxcui": ["1100066"], "spl_set_id": ["7dc158a2-fdfa-4a5f-8c28-0ce5650991db"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]", "Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE (31722-315-90)", "package_ndc": "31722-315-90", "marketing_start_date": "20230315"}], "brand_name": "IBUPROFEN AND FAMOTIDINE", "product_id": "31722-315_097eb368-0559-467f-8a1e-1082e82c15ed", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "31722-315", "generic_name": "Ibuprofen and famotidine", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "IBUPROFEN AND FAMOTIDINE", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "26.6 mg/1"}, {"name": "IBUPROFEN", "strength": "800 mg/1"}], "application_number": "ANDA216814", "marketing_category": "ANDA", "marketing_start_date": "20230315", "listing_expiration_date": "20261231"}